PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsgynecomastia
MeSH D006177 - gynecomastia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001941:Breast diseases
1 Company
1 Drug
$
Success rate
D006177: 
Gynecomastia
10 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AllerganTamoxifen Tamoxifen  2003-02-20   
ApotexTamoxifen Tamoxifen  2011-09-23   
AstraZenecaTamoxifen Nolvadex  1982-01-01   
Dr Reddys LaboratoriesTamoxifen Tamoxifen  2003-02-20   
Eugia Pharma SpecialtiesTamoxifen Tamoxifen  2020-08-14   
Mayne GroupTamoxifen Soltamox  2005-10-29   
MylanTamoxifen Tamoxifen  2003-02-20   
Roxane LaboratoriesTamoxifen Tamoxifen  2003-02-20   
TevaTamoxifen Tamoxifen  2003-04-28   
Zydus TherapeuticsTamoxifen Tamoxifen  2017-10-27   
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
33%
1/3
Phase 3
33%
1/3
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AstraZeneca
Tamoxifen,
Aglatimagene besadenovec,
Nepidermin
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use